Structured evidence table for Pecan Cardiometabolic Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Pecan Cardiometabolic Randomized Trial | Nuts are nutrient-dense whole foods, rich in unsaturated fatty acids, dietary fiber, plant sterols, tocopherols, and polyphenolic compounds, that have been consistently associated with favorable cardiometabolic outcomes in prospective cohorts and randomized trials. | 1 | Zhang Ziwei (2026) | The effect of pecan consumption on cardiometabolic risk factors: a systematic review and meta-analysis of randomized controlled trials |
| Pecan Cardiometabolic Randomized Trial | Large umbrella reviews and recent meta-analyses report that regular nut consumption (≈ 15–40 g/day) is associated with lower risks of cardiovascular disease, coronary heart disease and all-cause mortality, and that nut interventions reliably improve intermediate risk markers such as total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C) and triglycerides (TG) [–]. | 1 | Zhang Ziwei (2026) | The effect of pecan consumption on cardiometabolic risk factors: a systematic review and meta-analysis of randomized controlled trials |
| Pecan Cardiometabolic Randomized Trial | 7 9 8 10 12 Despite this robust literature for nuts collectively, evidence for individual nut species remains uneven. | 1 | Zhang Ziwei (2026) | The effect of pecan consumption on cardiometabolic risk factors: a systematic review and meta-analysis of randomized controlled trials |
| Pecan Cardiometabolic Randomized Trial | 1 2 3 6 Cardiometabolic diseases (including atherosclerotic cardiovascular disease and type 2 diabetes mellitus) remain leading causes of global morbidity and mortality, and dietary patterns are central determinants of both incidence and progression of these conditions [,]. | 1 | Zhang Ziwei (2026) | The effect of pecan consumption on cardiometabolic risk factors: a systematic review and meta-analysis of randomized controlled trials |
| Pecan Cardiometabolic Randomized Trial | Nuts such as almonds, walnuts, pistachios, pecans, and hazelnuts support cardiovascular health and help reduce chronic disease risk [,]. | 3 | Sandhu Amandeep K. (2025) | Pecans and Human Health: Distinctive Benefits of an American Nut |
| Pecan Cardiometabolic Randomized Trial | Their nutrient and health benefits have been elucidated by evidence-based diets like the Mediterranean and DASH diets. | 3 | Sandhu Amandeep K. (2025) | Pecans and Human Health: Distinctive Benefits of an American Nut |
| Pecan Cardiometabolic Randomized Trial | From a health perspective, pecans share many of the cardioprotective benefits associated with other nuts. | 3 | Sandhu Amandeep K. (2025) | Pecans and Human Health: Distinctive Benefits of an American Nut |
| Pecan Cardiometabolic Randomized Trial | 1 2 Tree nuts are nutrient-dense/health-promoting foods rich in unsaturated fats, fiber, plant protein, vitamins, minerals, and phytochemicals. | 3 | Sandhu Amandeep K. (2025) | Pecans and Human Health: Distinctive Benefits of an American Nut |
Source documents